Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
HY-083 by Hyloris Pharmaceuticals for Non Allergic Rhinitis: Likelihood of Approval
HY-083 is under clinical development by Hyloris Pharmaceuticals and currently in Phase I for Non Allergic Rhinitis. According to GlobalData,...